Last reviewed · How we verify

NCT05866289

Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure

Completed Last updated 19 May 2023
What this trial tests

trial testing Prone position in Survival, Prosthesis in 1,069 participants. Completed in 30 December 2021.

Timeline
1 March 2020
Primary endpoint
28 December 2021
30 December 2021

Quick facts

Lead sponsorMohammed VI University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,069
Start date1 March 2020
Primary completion28 December 2021
Estimated completion30 December 2021
Sites1 location across Morocco

Drugs / interventions tested

Conditions studied

Sponsor

Mohammed VI University Hospital

Who can join

Adults 18 to 80, any sex, with Survival, Prosthesis or Oxygen Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of our study is to evaluate the effectiveness of prone position in preventing intubation or death in spontaneously ventilated patients with COVID-19 with acute respiratory failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prone position

Trials testing the same drug.

Other recruiting trials for Survival, Prosthesis

Currently open trials in the same condition.

Other Mohammed VI University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05866289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing